You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 279 No. 8, February 25, 1998 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Thiamine Before Glucose to Prevent Wernicke Encephalopathy: Examining the Conventional Wisdom

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor.—In his letter, Dr Marinella1 claims, "Thiamine should be administered prior to a glucose load because cases of Wernicke encephalopathy have been reported after glucose administration in thiamine-deficient patients." The reference that supports this statement describes only 4 patients.2 The first was a 27-year-old woman with weight loss for more than 6 months, gastrointestinal symptoms for 3 days, and the onset of dizziness and blurring of her vision. She had tachycardia, confusion, ataxia, absent deep tendon reflexes, and horizontal nystagmus. After treatment with 3 L of 5% dextrose for more than 24 hours, her symptoms worsened. The second patient was a 79-year-old woman with schizophrenia, anorexia, weight loss, horizontal nystagmus, absent deep tendon reflexes, and a temperature of 33°C; the diagnosis was septicemia. After 2 L of dextrose, she developed bilateral sixth nerve palsies, disorientation, and coma. The third patient was a 45-year-old woman with end-stage renal . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

Pharmacologic Treatment of Alcohol Withdrawal
Mark A. Marinella
JAMA. 1997;278(16):1317.
PDF  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.